Ltb4 as vaccine adjuvant

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 31/557 (2006.01) A61K 39/04 (2006.01) A61K 39/145 (2006.01) A61K 39/245 (2006.01) A61P 31/06 (2006.01) A61P 31/16 (2006.01)

Patent

CA 2452008

The present invention relates to a vaccine adjuvant for enhancing immune response of an individual to a vaccine, which comprises an immune-enhancing effective amount of an LTB4 agent in association with a pharmaceutically effective vaccine carrier.

L'invention concerne un adjuvant de vaccin destiné à renforcer la réponse immunitaire d'un sujet à un vaccin, qui renferme une dose efficace renforçant la réponse immunitaire d'un agent LTB¿4? en association avec un transporteur de vaccin pharmaceutiquement efficace.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ltb4 as vaccine adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ltb4 as vaccine adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ltb4 as vaccine adjuvant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1571162

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.